MSX2 serves as a chondroprotective factor in osteoarthritis: insights from expression analysis and functional...

Area of Science:

• Biochemistry
• Molecular Biology
• Orthopedics

Background:

• Osteoarthritis (OA) is a prevalent degenerative joint disease with incompletely understood mechanisms of cartilage destruction.
• Muscle segment homeobox 2 (MSX2) is a transcription factor with potential roles in skeletal development and disease.

Purpose of the Study:

• To investigate the expression pattern of MSX2 in osteoarthritis.
• To elucidate the functional role of MSX2 in the pathogenesis of osteoarthritis.

Main Methods:

• Differential gene expression analysis of three GEO datasets (GSE55457, GSE12021, GSE114007) to assess MSX2 levels in OA vs. normal cartilage.
• Validation of MSX2 expression in human and mouse OA models using Western blot and RT-PCR.
• Functional studies involving MSX2 knockdown and overexpression via adeno-associated virus (AAV) vectors.
• Assessment of cartilage integrity, chondrocyte apoptosis, matrix markers (COL2, ACAN, MMP13), and inflammation (macrophage infiltration, TNFα).

Main Results:

• MSX2 was significantly downregulated in osteoarthritic cartilage from human patients and mouse models.
• MSX2 knockdown exacerbated cartilage degeneration, increased chondrocyte apoptosis, and disrupted matrix homeostasis by decreasing COL2 and ACAN while increasing MMP13.
• MSX2 knockdown enhanced inflammatory responses, indicated by increased macrophage infiltration and TNFα expression.
• MSX2 overexpression exhibited chondroprotective effects, improving cartilage morphology and reducing apoptosis.

Conclusions:

• MSX2 is a critical chondroprotective factor that maintains cartilage homeostasis.
• Downregulation of MSX2 contributes to OA pathogenesis by disrupting matrix homeostasis, promoting chondrocyte apoptosis, and enhancing inflammation.
• MSX2 represents a potential therapeutic target for osteoarthritis treatment.